MoonLake Immunotherapeutics Balance Sheet (2020-2026) | MLTX

Balance Sheet Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
1.10M1.03M8.04M0.02M41.20M39.51M50.13M501.79M318.17M451.17M458.44M342.79M375.66M180.43M271.57M306.68M350.74M334.52M298.49M
Short-term Investments (Quarter)
101.00M42.30M32.61M12.90M177.81M59.84M88.61M177.01M118.27M267.60M208.56M118.40M29.74M59.45M59.43M
Cash & Current Investments (Quarter)
1.10M1.03M8.04M101.02M83.50M72.11M63.03M501.79M495.98M511.01M547.05M519.80M493.92M448.03M480.13M425.08M380.48M393.97M357.92M
Receivables - Other (Quarter)
0.15M0.56M0.60M0.22M0.38M0.62M0.72M1.06M1.50M1.68M2.41M2.84M2.99M3.41M4.02M4.87M5.76M
Prepaid Assets (Quarter)
0.23M0.18M1.45M0.14M5.11M4.48M4.18M3.08M3.96M3.31M2.10M5.04M15.41M15.98M23.42M23.15M26.99M26.71M22.86M32.96M
Current Assets (Quarter)
1.33M1.21M9.64M116.16M98.38M88.54M76.51M66.50M506.37M500.01M514.17M553.59M536.88M512.32M474.29M506.26M455.48M411.21M421.69M396.64M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.05M0.06M0.05M0.05M0.05M0.04M0.04M0.32M0.51M0.48M0.58M0.72M0.71M0.67M0.62M0.58M0.53M
Long-Term Investments (Quarter)
115.04M115.04M115.04M115.05M
Intangibles (Quarter)
Goodwill & Intangibles (Quarter)
Other Non-Current Assets (Quarter)
8.42M6.32M4.13M2.06M1.70M1.70M0.59M0.60M1.34M
Non-Current Assets (Quarter)
115.04M115.04M0.05M115.05M0.06M0.05M0.33M0.29M0.25M0.21M12.37M10.53M8.00M5.90M3.64M5.00M4.62M3.12M2.74M3.73M
Assets (Quarter)
116.37M116.25M9.68M231.21M98.43M88.59M76.84M66.80M506.62M500.22M526.54M564.12M544.88M518.21M477.93M511.26M460.10M414.33M424.43M400.37M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
1.57M0.79M1.06M0.25M3.83M4.36M3.40M1.84M3.48M5.14M10.71M8.99M12.01M17.08M25.28M29.55M23.38M
Notes Payables (Quarter)
15.00M0.15M
Payables (Quarter)
16.57M0.15M0.79M1.06M0.25M3.83M4.36M3.40M1.84M3.48M5.14M10.71M8.99M12.01M17.08M25.28M29.55M23.38M
Accumulated Expenses (Quarter)
0.09M2.06M4.52M0.03M3.07M4.96M7.26M3.30M2.62M6.75M6.93M4.12M5.82M7.93M12.10M10.54M8.73M21.59M14.69M21.81M
Short term Debt (Quarter)
15.00M
Current Leases (Quarter)
0.15M0.16M0.16M0.16M1.20M1.30M1.32M1.44M1.37M1.43M1.55M1.50M1.23M0.92M
Total Current Liabilities (Quarter)
0.09M2.06M21.09M202.79M3.86M6.02M7.67M7.28M7.13M10.31M9.97M8.91M12.28M20.08M22.46M23.98M27.36M48.37M45.48M46.11M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
4.03M4.03M4.03M4.03M
Pension (Quarter)
1.32M0.02M0.00M1.32M0.31M0.32M0.26M2.49M0.46M0.54M0.69M0.62M0.54M0.57M0.55M0.35M
Preferred Stock Liabilities (Quarter)
107.26M115.00M115.00M
Minority Interest (Quarter)
31.04M27.28M19.87M17.11M9.31M64.71M17.82M9.83M9.37M7.31M6.57M5.06M4.21M2.29M
Operating Leases (Quarter)
0.13M0.09M0.21M0.17M2.50M2.36M2.02M3.38M1.46M1.14M2.39M1.99M0.37M0.86M
Total Non-Current Liabilities (Quarter)
0.24M0.02M0.00M0.41M0.41M0.38M0.27M3.08M2.82M2.56M2.63M2.08M74.70M74.79M74.78M74.47M100.24M
Total Liabilities (Quarter)
4.12M6.08M21.33M206.82M3.88M6.02M8.08M7.68M7.51M10.58M13.05M11.73M14.85M22.71M24.54M98.68M102.15M123.14M119.95M146.35M
Shareholder's Equity
Total Debt (Quarter)
15.00M
Common Equity (Quarter)
0.83M-3.10M-11.65M-25.27M94.56M82.57M68.77M59.11M499.11M489.64M513.49M552.39M530.03M495.50M453.39M412.58M357.94M291.19M304.48M254.02M
Shareholder's Equity (Quarter)
0.83M-3.10M-11.65M-25.27M94.56M82.57M68.77M59.11M499.11M489.64M513.49M552.39M530.03M495.50M446.82M412.58M357.94M288.91M304.48M254.02M
Liabilities and Shareholders Equity (Quarter)
116.37M116.25M9.68M231.21M98.43M88.59M76.84M66.80M506.62M500.22M526.54M564.12M544.88M518.21M477.93M511.26M460.10M414.33M424.43M400.37M
Treasury Shares (Quarter)
1.94M0.77M2.78M1.94M2.24M2.24M0.63M2.22M2.22M2.22M0.25M0.19M0.19M0.19M0.50M
Retained Earnings (Quarter)
-2.75M-4.84M-53.64M-9.76M0.13M0.25M0.35M0.34M-99.79M2.88M2.36M-130.33M3.26M-189.99M5.00M-275.54M0.52M0.28M0.60M0.32M
Preferred Shares (Quarter)
0.07M